-LRB-/-LRB- During/IN its/PRP$ centennial/JJ year/NN ,/, The/DT Wall/NNP Street/NNP Journal/NNP will/MD report/VB events/NNS of/IN the/DT past/JJ century/NN that/DT *T*-1/-NONE- stand/NN as/IN milestones/NNS of/IN American/JJ business/NN history/NN ./. -RRB-/-RRB-
LUTHER/NNP BURBANK/NNP CROSS-BRED/VBD PLANTS/NNS *-1/-NONE- to/TO produce/VB the/DT billion-dollar/JJ Idaho/NNP potato/NN ./.
Bioengineers/NNS set/VBD out/RP *-1/-NONE- to/TO duplicate/VB that/DT feat/NN --/: scientifically/RB and/CC commercially/RB --/: with/IN new/JJ life/NN forms/NNS ./.
In/IN 1953/CD ,/, James/NNP Watson/NNP and/CC his/PRP$ colleagues/NNS unlocked/VBD the/DT double/JJ helix/NN of/IN DNA/NN -LRB-/-LRB- deoxyribonucleic/JJ acid/NN -RRB-/-RRB- ,/, the/DT genetic/JJ key/NN to/TO heredity/NN ./.
Twenty/CD years/NNS later/RB ,/, two/CD California/NNP academics/NNS ,/, Stanley/NNP Cohen/NNP and/CC Herbert/NNP Boyer/NNP ,/, made/VBD ``/`` recombinant/JJ ''/'' DNA/NN ,/, *-1/-NONE- transplanting/VBG a/DT toad/NN 's/POS gene/NN into/IN bacteria/NNS ,/, which/WDT then/RB *T*-104/-NONE- reproduced/VBD toad/NN genes/NNS ./.
When/WRB Boyer/NNP met/VBD Robert/NNP Swanson/NNP ,/, an/DT M.I.T.-trained/JJ chemist-turned-entrepreneur/NN in/IN 1976/CD *T*-1/-NONE- ,/, they/PRP saw/VBD dollar/NN signs/NNS ./.
With/IN $/$ 500/CD *U*/-NONE- apiece/RB and/CC an/DT injection/NN of/IN outside/JJ capital/NN ,/, they/PRP formed/VBD Genentech/NNP Inc/NNP ./.
Commercial/JJ gene-splicing/NN was/VBD born/VBN *-1/-NONE- ./.
Genentech/NNP 's/POS first/JJ product/NN ,/, a/DT brain/NN protein/NN called/VBD */-NONE- somatostatin/NN ,/, proved/VBD its/PRP$ technology/NN ./.
The/DT next/JJ 0/-NONE- *T*-1/-NONE- to/TO be/VB cloned/VBN *-2/-NONE- ,/, human/JJ insulin/NN ,/, had/VBD market/NN potential/NN and/CC Genentech/NNP licensed/VBD it/PRP to/TO Eli/NNP Lilly/NNP ,/, which/WDT *T*-105/-NONE- produced/VBD 80/CD %/NN of/IN the/DT insulin/NN used/VBN */-NONE- by/IN 1.5/CD million/CD U.S./NNP diabetics/NNS ./.
Their/PRP$ laboratory/NN credentials/NNS established/VBN */-NONE- ,/, Boyer/NNP and/CC Swanson/NNP headed/VBD for/IN Wall/NNP Street/NNP in/IN 1980/CD ./.
At/IN the/DT time/NN ,/, Genentech/NN had/VBD only/RB one/CD profitable/JJ year/NN behind/IN it/PRP -LRB-/-LRB- a/DT modest/JJ $/$ 116,000/CD *U*/-NONE- on/IN revenue/NN of/IN $/$ 2.6/CD million/CD *U*/-NONE- in/IN 1979/CD -RRB-/-RRB- and/CC no/DT product/NN of/IN its/PRP$ own/JJ on/IN the/DT market/NN ./.
Nonetheless/RB ,/, the/DT $/$ 36/CD million/CD *U*/-NONE- issue/NN 0/-NONE- they/PRP floated/VBD *T*-1/-NONE- in/IN 1980/CD opened/VBD at/IN $/$ 35/CD *U*/-NONE- and/CC leaped/VBD to/TO $/$ 89/CD *U*/-NONE- within/IN 20/CD minutes/NNS ./.
The/DT trip/NN from/IN the/DT test/NN tube/NN was/VBD not/RB without/IN snags/NNS ./.
Boyer/NNP and/CC Cohen/NNP ,/, for/IN instance/NN ,/, both/DT still/RB university/NN researchers/NNS ,/, had/VBD *-1/-NONE- to/TO be/VB talked/VBN *-2/-NONE- into/IN */-NONE- applying/VBG for/IN a/DT patent/NN on/IN their/PRP$ gene-splicing/NN technique/NN --/: and/CC then/RB the/DT Patent/NNP Office/NNP refused/VBD *-3/-NONE- to/TO grant/VB it/PRP ./.
That/DT judgment/NN ,/, in/IN turn/NN ,/, was/VBD reversed/VBN *-1/-NONE- by/IN the/DT U.S./NNP Supreme/NNP Court/NNP ,/, */-NONE- leaving/VBG Cohen/NNP and/CC Boyer/NNP holding/VBG the/DT first/JJ patents/NNS for/IN */-NONE- making/VBG recombinant/JJ DNA/NNP -LRB-/-LRB- now/RB assigned/VBN to/TO their/PRP$ schools/NNS -RRB-/-RRB- ./.
Gene-splicing/NN now/RB is/VBZ an/DT integral/JJ part/NN of/IN the/DT drug/NN business/NN ./.
Genentech/NN 's/POS 1988/CD sales/NNS were/VBD $/$ 335/CD million/CD *U*/-NONE- ,/, both/CC from/IN licensing/NN and/CC its/PRP$ own/JJ products/NNS ./.

